Let’s start up with the current stock price of Translate Bio Inc. (TBIO), which is $29.46 to be very precise. The Stock rose vividly during the last session to $30.87 after opening rate of $30.82 while the lowest price it went was recorded $29.21 before closing at $30.61.
Recently in News on July 7, 2021, Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4). Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today reported that on July 6, 2021, the Company granted non-qualified stock options to purchase an aggregate of 177,400 shares of the Company’s common stock to nine new employees. These grants were made pursuant to the Company’s 2021 Inducement Stock Incentive Plan, were approved by the Company’s Inducement Grant Subcommittee of the board of directors, and were made as a material inducement to each employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation. You can read further details here
Translate Bio Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $34.64 on 02/08/21, with the lowest value was $15.44 for the same time period, recorded on 03/25/21.
Translate Bio Inc. (TBIO) full year performance was 50.61%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Translate Bio Inc. shares are logging -14.95% during the 52-week period from high price, and 147.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $11.91 and $34.64.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 731922 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Translate Bio Inc. (TBIO) recorded performance in the market was 59.85%, having the revenues showcasing 43.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.19B, as it employees total of 122 workers.
Market experts do have their say about Translate Bio Inc. (TBIO)
During the last month, 6 analysts gave the Translate Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 21.16, with a change in the price was noted +6.12. In a similar fashion, Translate Bio Inc. posted a movement of +26.22% for the period of last 100 days, recording 1,057,050 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TBIO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Translate Bio Inc. (TBIO)
Raw Stochastic average of Translate Bio Inc. in the period of last 50 days is set at 87.03%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 82.08%. In the last 20 days, the company’s Stochastic %K was 90.89% and its Stochastic %D was recorded 93.45%.
Bearing in mind the latest performance of Translate Bio Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 59.85%. Additionally, trading for the stock in the period of the last six months notably improved by 32.35%, alongside a boost of 50.61% for the period of the last 12 months. The shares increased approximately by 1.38% in the 7-day charts and went down by 57.20% in the period of the last 30 days. Common stock shares were driven by 43.57% during last recorded quarter.